Closed transaction

PharmaX Solutions sold to BioPhorum (Five Arrows)

PharmaX Solutions was sold to BioPhorum (

Advised by
Client
Counterparty
Deal stage
Closed transaction
Service
Sell
Sector
Healthcare
Sub-sector
Other Healthcare
Contact
ubreitenstein@hoffmann-partner.com

Deal details

Hoffmann & Partner, the Basel-based M&A advisory firm specialising in healthcare, acted as the exclusive financial advisor to the shareholders of PharmaX Solutions.

BioPhorum, a portfolio company of Five Arrows, has acquired PharmaX Solutions, a consultancy specialising in digital transformation and end-to-end digital manufacturing solutions across pharmaceutical manufacturing and production environments.

PharmaX Solutions specialises in the design, implementation, and integration of digital manufacturing systems, including MES, automation platforms, and quality systems, with deep expertise in GxP-regulated environments and IT/OT convergence. PharmaX Solutions operates across four international offices located in Germany, Spain, Denmark and Switzerland.

BioPhorum enables the global biopharmaceutical industry to connect, collaborate, and accelerate progress for the benefit of all. Founded in 2004, BioPhorum has evolved from an end user forum into a globally trusted, industry led organisation that brings together senior leaders and subject matter experts from across the biopharma value chain.

Five Arrows is the alternative assets arm of Rothschild & Co and has €33 billion AuM with offices in Paris, London, New York, Los Angeles, San Francisco and Luxembourg.

Urs Breitenstein Partner Hoffmann & Partner Dr. Urs Breitenstein is a founding Partner of Hoffman & Partner. View profile
Simon Marti Senior Manager M&A Hoffmann & Partner Simon Marti is a Senior Manager at Hoffmann & Partner, where he advises clients on mergers and acquisitions (M&A) as well as valuation matters. View profile
Niklas Schehrer Senior Consultant M&A Hoffmann & Partner Niklas Schehrer is a Senior Consultant at Hoffmann & Partner, where he specializes in Mergers & Acquisitions (M&A) and business valuation. View profile

Hoffmann & Partner latest deals

Advisory

houzy and myky join forces under Swiss Digital Home AG.

Where
Switzerland
Year
2026
Sell-side advisory

Willmann GmbH & Co. KG was sold to Albrecht Group GmbH.

Where
Germany
Year
2026
Sell-side advisory

House of Flexwork was acquired by Synergie Group.

Where
Switzerland
Year
2026
Sell-side advisory

Nostos Genomics was sold to Limbus Medical Technologies (varvis®).

Where
Germany
Year
2025

More by Hoffmann & Partner

More deals in Healthcare

Sell-side advisory

Allied Group has acquired majority stake in Tzamal Medical.

Where
Israel
Year
2026
Sell-side advisory

Nostos Genomics was sold to Limbus Medical Technologies (varvis®).

Where
Germany
Year
2025
Sell-side advisory

NUTRIBRAIN was sold to LABORATORIOS RUBIÓ.

Where
Spain
Year
2025

More Healthcare

More deals in Europe

Sell-side advisory

Ocean Property Services Group sold to Lomond.

Where
United Kingdom
Year
2026
Advisory

John Henry Group.

Where
United Kingdom
Year
2026
Advisory

houzy and myky join forces under Swiss Digital Home AG.

Where
Switzerland
Year
2026
Sell-side advisory

Fibreactive sold to discoverIE Group plc.

Where
United Kingdom
Year
2026

More Europe

Membership

Gain worldwide reach with CapFive M&A professionals

The professionals of CapFive have been carefully selected on the basis of reputation, relationships, proven track record and knowledge of local markets.

Become a member

Get in touch

Find an adviser.

From a first valuation to signed completion, CapFive member firms advise on sell-side, buy-side, corporate finance and debt.

Share what you are planning and we will connect you with an adviser who has done it before, and who can bring in colleagues across borders when the deal needs them.

Contact us